MA Bundle of Bills Testimony (2021)
PCMA submits testimny to the Joint Committee on Financial Services regarding a bucket list of bills addressing a wide range of PBM regulations.
CA SB 524 Veto Letter #1 (2021)
In PCMA’s veto request letter to Governor Newsom, PCMA suggests that California use proposed alternative language for “patient steering”
ME HB 1450 Testimony (2021)
PCMA submits testimony in opposition of HB 1450. The bill would permit PBMs to include affiliate pharmacies in communications to customers regarding network pharmacies and
ME SB 97 Testimony (2021)
PCMA submits testimony regarding SB 97, a bill that relates to in-network retail pharmacies delivering prescriptions as an ancillary service.
IL SB 2008 Cost Analysis Infographic (2021)
Infographic highlighting the estimated cost of IL SB 2008, a bill seeking to enact AWP provisions and a fiduciary mandate.
IL SB 2008 Talking Points (2021)
Talking points for IL SB 2008. As an omnibous PBM bill, it would restrict preferred pharmacy networks by adding an AWP requirement and include a
IL SB 2008 Testimony (2021)
PCMA submits testimony opposing SB 2008. As an omnibous PBM bill, it would restrict preferred pharmacy networks by adding an AWP requirement and include a
IA HF 729 Cost Analysis (2021)
If enacted, IA HF 729 would cost the state $1.2 billion over next 10 years. HF 729 would instittue Any Willing Provider rules and restrict
